With reference to the earlier intimations letter dated May 08, 2017 and May 13, 2017, regarding Board Meeting which is scheduled on May 19, 2017, inter alia, to consider, approve and take on record the Audited Financial Results of the Company for the quarter and year ended March 31, 2017 and to recommend final dividend, if any, for the financial year ending March 31, 2017 respectively, Claris Lifesciences Ltd has now informed BSE that the said Board...